iShares NASDAQ US Biotechnology UCITS ETF

An exchange-traded fund (ETF) is an investment product that holds a basket of assets such as stocks, bonds, futures, or other instruments, and trades on an exchange like a regular stock.

Why investors use ETFs:
– Easy way to gain exposure to sectors like stocks, bonds, real estate, or crypto
– Lower barrier to entry compared to buying individual assets
– Can help reduce volatility through diversification

Explore the largest ETFs: they are considered the most trusted and secure and will help you start your journey on the ETF markets.

Markets don't sleep, here's what's going on with 2B70 at the moment:
– REG - iShares IV NASDAQ $ - Dividend Declaration
– REG - iShares IV NASDAQ $ - Net Asset Value(s)
– REG - iShares IV US BTEC $ - Net Asset Value(s)

See more updates in real-time with our News Flow.

2B70 net asset value (NAV) is 9.46 EUR. It represents the total value of the fund's assets less liabilities.

Other key metrics:
– 2B70 AUM — ‪1.13 B‬ EUR
– 2B70 discount/premium to NAV — 0.44%
– 2B70 expense ratio — 0.37%

Explore more funds in our list of largest ETFs.

To put today's price into context, compare 2B70's performance across different time periods:
– 1 day — +0.69%
– 1 week — +3.79%
– 1 month — +4.84%

2B70's all-time low was 3.617 EUR on Dec 27, 2018, while its all-time high was 9.753 EUR on Oct 30, 2026.

For a deeper look at market activity, explore the ETF Heatmap and the 2B70 price chart.

The safest way to buy 2B70 is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade 2B70 directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your exchange, and log in
– Start trading: Place orders directly from the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.

iShares NASDAQ US Biotechnology UCITS ETF expense ratio is 0.37%. It represents the annual cost of managing the fund, expressed as a percentage of its assets.

Other key metrics:
– 2B70 AUM — ‪1.13 B‬ EUR
– 2B70 NAV — 9.46 EUR
– 2B70 discount/premium to NAV — 0.44%

Explore more ETFs with highest expense ratio and find even more stats in the ETF Screener.

Before making an investment decision, it's important to understand how the ETF works and whether it aligns with your goals and risk tolerance. Consider factors such as:
– The ETF's holdings
– Whether it is passively or actively managed
– Whether it uses leverage
– Its costs, performance, and other characteristics relevant to your strategy

You can also use technical analysis to assess current market conditions. Our summary Technical Ratings for 2B70 are:
– Today — buy
– 1 week — strong buy
– 1 month — buy

For a deeper analysis, explore other 2B70 technicals and follow the latest ETF news.

2B70 trades at a premium (0.44%).

Premium/discount to net asset value (NAV) expresses the difference between the ETF's price and its NAV value.
– A positive percentage indicates a premium, meaning the fund trades at a higher price than the calculated NAV.
– A negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.

You can find more funds in the list of highest premium to NAV.

The fund's management style is passive, aiming to replicate the performance of the NASDAQ / Biotechnology by holding the same assets in similar proportions.

What it means:
– Index tracking: Mirrors the composition and weight of the underlying index
– Low turnover: Fewer trades compared to active funds
– May be more cost-efficient: Passive approach typically results in lower fees (expense ratio)

Combine this knowledge with other metrics:
– 2B70 AUM — ‪1.13 B‬ EUR
– 2B70 NAV — 9.46 EUR
– 2B70 expense ratio — 0.37%

Explore more details in the Profile section.

Today, 2B70 trades at 9.552 EUR.

For broader market analysis, dive into the technicals on the 2B70 price chart and read the latest 2B70 news:
– REG - iShares IV NASDAQ $ - Dividend Declaration
– REG - iShares IV NASDAQ $ - Net Asset Value(s)
– REG - iShares IV US BTEC $ - Net Asset Value(s)

2B70 assets under management (AUM) is ‪1.13 B‬ EUR. It represents the total market value of all assets held by the fund.

Other key metrics:
– 2B70 NAV — 9.46 EUR
– 2B70 expense ratio — 0.37%
– 2B70 premium/discount to NAV — 0.44%

Explore more funds in our list of largest ETFs. For deeper analysis, check the ETF Screener.

2B70 fund flows account for ‪223.04 M‬ EUR, showing the net amount of money entering or leaving the fund over 1 year. Many traders use it to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

Other key metrics:
– 2B70 AUM — ‪1.13 B‬ EUR
– 2B70 discount/premium to NAV — 0.44%
– 2B70 expense ratio — 0.37%

For broader market analysis, read the latest market news and read the ETF trading ideas.

2B70 invests in stocks. See more details in our Profile section.

No, 2B70 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.

No, 2B70 doesn't pay dividends to its holders.

2B70 shares are issued by BlackRock, Inc.